Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Proteogenomic and metabolomic characterization of human glioblastoma

Cancer Cell(2021)10.1016/j.ccell.2021.01.006Source: DataRank Database

Proteogenomic and metabolomic characterization of human glioblastoma is a research paper published in Cancer Cell (2021). On theSindex it has a DataRank of 8.7. It has been cited 702 times, with 200 citing works in its 1-hop citation network.

N/A

8.7DataRank · unranked

Scored on demand from live citation data

Open Access702 citations · 200 citing works in its network

Download PDF

Cite:

Linked data & code

geo hpa doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (18 grants)OA: bronzeTopics (20)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC)Annotations (3)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 11%Citation Network 89%

Base Score Contribution

0.983

From this paper's citation signal

Citation Network Contribution

7.7

From 200 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 200 citers.

A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma
BMC Cancer202296 citations21 referencesContributes 0.218
Complex heatmap visualization
iMeta20221,883 citations36 referencesContributes 0.209
Genetic mutation patterns among glioblastoma patients in the Taiwanese population – insights from a single institution retrospective study
Cancer Gene Therapy202422 citations25 referencesContributes 0.125
Metabolic remodeling in glioblastoma: a longitudinal multi-omics study
Acta Neuropathologica Communications202418 citations26 referencesContributes 0.113
DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients
Neuro-Oncology202271 citations40 referencesContributes 0.107

Authors (100)

Alla Y. Karpova ORCID,Marina A. Gritsenko,Jennifer Kyle ORCID,Song Cao ORCID,Yize Li ORCID

Live enrichment

PubMed:33577785 PMC:PMC8044053

U.S. Department of Energy

Grant: DE-AC05-76RL01830

National Human Genome Research Institute

Grant: R01HG009711

National Human Genome Research Institute

Grant: R01NS107833

National Cancer Institute

Grant: U01CA214125

National Cancer Institute

Grant: U24CA210954

National Cancer Institute

Grant: U24CA210955

National Cancer Institute

Grant: U24CA210967

National Cancer Institute

Grant: U24CA210972

National Cancer Institute

Grant: U24CA210979

National Cancer Institute

Grant: U24CA210985

National Cancer Institute

Grant: U24CA210986

National Cancer Institute

Grant: U24CA210993

NINDS NIH HHS

Grant: K08 NS102474

NIEHS NIH HHS

Grant: P30 ES010126

NHGRI NIH HHS

Grant: T32 HG000045

NCI NIH HHS

Grant: U24 CA160019

National Institutes of Health

Orbus Therapeutics

bronzeLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

publisherhttp://www.cell.com/article/S1535610821000507/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610821000507?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610821000507?httpAccept=text/plain

repositoryhttps://www.osti.gov/biblio/1768662

repositoryhttps://www.osti.gov/biblio/1778831

MeSH Terms

HumansGlioblastomaBrain NeoplasmsProteomicsComputational BiologyPhosphorylationMutationPhospholipase C gammaProtein Tyrosine Phosphatase, Non-Receptor Type 11MetabolomicsProteogenomics

Keywords

SignalingProteomicsGlioblastomametabolomeProteogenomicsLipidomeAcetylomeCptacSingle Nuclei Rna-seq

The Clinical Proteomic Tumor Analysis Consortium Glioblastoma Multiforme Collection (CPTAC-GBM)

10.7937/k9/tcia.2018.3rje41q1The Cancer Imaging Archive

Additional file 1 of Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma

10.6084/m9.figshare.19728584.v1figshare

Additional file 1 of Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma

10.6084/m9.figshare.19728584figshare

Additional file 2 of Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma

10.6084/m9.figshare.19728587.v1figshare

Additional file 2 of Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma

10.6084/m9.figshare.19728587figshare

Additional file 3 of Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma

10.6084/m9.figshare.19728590.v1figshare

Additional file 3 of Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma

10.6084/m9.figshare.19728590figshare

Additional file 4 of Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma

10.6084/m9.figshare.19728596.v1figshare

Additional file 4 of Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma

10.6084/m9.figshare.19728596figshare

Additional file 5 of Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma

10.6084/m9.figshare.19728599.v1figshare

Additional file 5 of Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma

10.6084/m9.figshare.19728599figshare

Additional file 2 of Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML

10.6084/m9.figshare.20390799.v1figshare

Additional file 2 of Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML

10.6084/m9.figshare.20390799figshare

Additional file 1 of Understanding of bacterial lignin extracellular degradation mechanisms by Pseudomonas putida KT2440 via secretomic analysis

10.6084/m9.figshare.21443757.v1figshare

Additional file 1 of Understanding of bacterial lignin extracellular degradation mechanisms by Pseudomonas putida KT2440 via secretomic analysis

10.6084/m9.figshare.21443757figshare

Additional file 3 of Understanding of bacterial lignin extracellular degradation mechanisms by Pseudomonas putida KT2440 via secretomic analysis

10.6084/m9.figshare.21443763.v1figshare

Additional file 3 of Understanding of bacterial lignin extracellular degradation mechanisms by Pseudomonas putida KT2440 via secretomic analysis

10.6084/m9.figshare.21443763figshare

Additional file 2 of Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China

10.6084/m9.figshare.21506861.v1figshare

Additional file 2 of Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China

10.6084/m9.figshare.21506861figshare

Additional file 3 of Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China

10.6084/m9.figshare.21506864.v1figshare

Related Papers (10)

Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

N/A

9.1DataRank · unranked

Cell(2020)

co-cited

10.1016/j.cell.2020.06.013

Proteogenomic characterization of pancreatic ductal adenocarcinoma

N/A

7.9DataRank · unranked

Cell(2021)

co-cited

10.1016/j.cell.2021.08.023

A proteogenomic portrait of lung squamous cell carcinoma

N/A

7.2DataRank · unranked

Cell(2021)

co-cited

10.1016/j.cell.2021.07.016

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

N/A

8.1DataRank · unranked

Cell(2020)

co-cited

10.1016/j.cell.2020.10.036

Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma

N/A

8.3DataRank · unranked

Cell stem cell(2020)

co-cited

10.1016/j.stem.2019.11.015

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

N/A

3.6DataRank · unranked

Cancer Cell(2022)

co-citedsame journal

10.1016/j.ccell.2022.12.001

Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability

N/A

2.4DataRank · unranked

Cell Reports Medicine(2020)

co-cited

10.1016/j.xcrm.2020.100004

Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer

N/A

0.878DataRank · unranked

Cell(2020)

co-cited

10.1016/j.cell.2020.10.044

Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches

Cancer Research(2020)

co-cited

10.1158/0008-5472.can-19-2961

AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models

Top 1%

9.8DataRank

Nucleic Acids Research(2021)

co-cited

10.1093/nar/gkab1061

Proteogenomic and metabolomic characterization of human glioblastoma

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (100)

Funding (18 grants)

Open Access

Topics

Linked Datasets (25)

Annotations (Europe PMC)

Related Papers (10)